Suppr超能文献

八例患者出现第二种副肿瘤性神经系统综合征的迟发性发作。

Delayed onset of a second paraneoplastic neurological syndrome in eight patients.

机构信息

Hospices Civils de Lyon, Hôpital Neurologique, Centre de Référence Maladie Rare Syndromes Neurologiques Paranéoplasiques, Lyon, France.

出版信息

J Neurol Neurosurg Psychiatry. 2010 Aug;81(8):937-9. doi: 10.1136/jnnp.2009.190199. Epub 2010 Jun 18.

Abstract

BACKGROUND

The occurrence of a second delayed paraneoplastic neurological syndrome (PNS), different from the first, in the same patient, is not well known. However, recognition of this possibility is important in the management of the patient with PNS.

OBJECTIVE

To describe eight patients who presented with two different PNS with a time delay of months to years.

DESIGN, SETTING AND PATIENTS: Retrospective analysis of eight patients, included in the European PNS database, with two different PNS that occurred months to years apart.

RESULTS

The median delay between the two different PNS was 15 months. The antibody repertoire did not change between the two episodes. Anti-Hu was detected in five patients, and anti-CV2 and anti-Ri in one each. One patient did not present onconeural antibodies. Lung cancer was diagnosed in six patients. In five patients, the second PNS revealed a cancer relapse (n=4) or a second cancer (n=1) and in three it occurred without evidence of tumour recurrence. In these three patients, all with anti-Hu antibodies, the second episode consisted of a lower motor neuron disease. Median survival was not reached after a median follow-up of 5 years.

CONCLUSIONS

A second PNS can reveal a cancer relapse but can also arise in its absence. The long survival of patients with a second PNS suggests that the immune response might be more effective in controlling the cancer.

摘要

背景

在同一患者中出现与首次不同的第二种迟发性副肿瘤神经系统综合征(PNS)并不常见。然而,认识到这种可能性对于 PNS 患者的管理非常重要。

目的

描述 8 例患者,他们出现了两种不同的 PNS,间隔数月至数年。

设计、地点和患者:回顾性分析 8 例患者,这些患者被纳入欧洲 PNS 数据库,他们患有两种不同的 PNS,间隔数月至数年。

结果

两种不同的 PNS 之间的中位间隔时间为 15 个月。两次发作之间的抗体谱没有变化。五例患者检测到抗 Hu 抗体,一例患者检测到抗 CV2 和抗 Ri 抗体。一例患者未出现神经肿瘤相关抗体。六例患者诊断为肺癌。在五例患者中,第二种 PNS 提示癌症复发(n=4)或第二种癌症(n=1),在三种患者中,癌症无复发证据。在这三例患者中,均有抗 Hu 抗体,第二次发作表现为下运动神经元疾病。在 5 年的中位随访后,中位生存期未达到。

结论

第二种 PNS 可能提示癌症复发,但也可能在无癌症复发的情况下出现。第二种 PNS 患者的长期生存表明免疫反应可能更有效地控制癌症。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验